Jason Hedges, MD
Urology · Portland, ORNPI 1639384720
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Coloplast at 37.0% of the total. Reporting peaked in 2024 at $206 and has fallen 83.3% since, to $34 in 2025. That places this record below the midpoint for urology clinicians in OR, where the typical reported total is $1,472.
Across 10 payments — averaging $94.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$350
- Boston Scientific$206
- Urogen Pharma, Inc.$150
- Procept Biorobotics Corporation$114
- Bayer$75
- Antares Pharma, Inc.$50
Across 1 payment — averaging $13,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$13K
What the payments were for
- Food & beverage$945100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 4 | $350 |
| Boston Scientific | 2 | $206 |
| Urogen Pharma, Inc. | 1 | $150 |
| Procept Biorobotics Corporation | 1 | $114 |
| Bayer | 1 | $75 |
| Antares Pharma, Inc. | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$240
- JELMYTO$150
- AquaBeam Robotic System$114
- GENERAL ERECTILE DYSFUNCTION$112
How this compares
$945 in reported general payments places this provider in the 40th percentile of 153 urology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone | 37 | $9,664 |
| Tamsulosin Hcl | 165 | $3,034 |
| Finasteride | 91 | $1,413 |
| Testosterone Cypionate | 29 | $1,079 |
| Trospium Chloride | 15 | $1,028 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 14 | $555 |
| Fluconazole | 11 | $437 |
| Cephalexin | 12 | $355 |
| Anastrozole | 38 | $248 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $122 |
| Meloxicam | 17 | $78 |
Paid to pharmacies, not to this prescriber.
Other urology in Portland
- Lance MarrPortland$323K
- da David JiangPortland$65K
- Amir PatelPortland$36K
- James TycastPortland$35K
- Sudhir IsharwalPortland$30K
- Ian MetzlerPortland$23K
- Sara Spettel AliyarPortland$21K
- Daniel JanoffPortland$15K
- James BreseePortland$14K
- Stanley MyersPortland$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.